Tag: Ibrance

April 4, 2019 Off

U.S. FDA Approves IBRANCE for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer

Approval of expanded indication based predominately on real-world data NEW YORK–(BUSINESS WIRE)–Pfizer (NYSE:PFE) today announced that the U.S. Food and…

December 22, 2016 Off

FDA accepts Pfizers breast cancer drug supplemental New Drug Application

By Dino Mustafić

Pfizer is moving forward with Ibrance breast cancer drug as the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA).